PAX8-mediated activation of the wt1 tumor suppressor gene

EMBO Journal

Volumn 15, Issue 16, 1996, Pages 4297-4306

  Dehbi, Mohammed ^a   Pelletier, Jerry ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Kidney development; Pax 8; Wilms tumor; wt1

Indexed keywords

TRANSCRIPTION FACTOR;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; EPITHELIUM CELL; GENE ACTIVATION; HUMAN; HUMAN CELL; KIDNEY DEVELOPMENT; MESENCHYME; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0029756801     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb00804.x     Document Type: Article

References (63)

1. Adams, B., Drfler, P., Aguzzi, A., Kozmik, Z., Urnek, P., Maurer-Fogy, I. and Busslinger, M. (1992) Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev., 6, 1589-1607.
2. Auffray, C. and Rougeon, F. (1980) Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur. J. Biochem., 107, 303-314.
3. Barberis, A., Widenhorn, K., Vitelli, L. and Busslinger, M. (1990) A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation. Genes Dev., 4, 849-859.
4. Barr, F.G., Galili, N., Holick, J., Biegel, J.A., Rovera, G. and Emanuel, B.S. (1993) Rearrangment of the PAX3 paired box gene in the paediatric solid tumor alveolar rhabdomyosarcoma. Nature Genet., 3, 113-117.
5. Beckwith, J.B., Kiviat, N.B. and Bonadio, J.F. (1990) Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms tumor. Pediatr. Pathol., 10, 1-36.
6. Bopp, D., Burri, M., Baumgartner, S., Frigerio, G. and Noll, M. (1986) Conservation of a large protein domain in the segmentation gene paired and in functionally related genes of Drosophila. Cell, 47, 1033-1040.
7. Bruening, W. and Pelletier, J. (1994) Denys-Drash syndrome: a role for the WT1 tumor suppressor gene in urogenital development. Semin. Dev. Biol., 5, 333-343.
8. Bruening, W. and Pelletier, J. (1996) A non-AUG translational initiation event generates novel WT1 isoforms. J. Biol. Chem., 271, 8646-8654.
9. Call, K.M. et al. (1990) Isolation and characterization of a zinc linger polypeptide gene at the human chromosome 11 Wilms tumor locus. Cell, 60, 509-520.
10. Chalepakis, G., Fritsch, R., Fickenscher, H., Deutsch, U., Goulding, M. and Gruss, P. (1991) The molecular basis of the undulated/Pax-1 mutation. Cell, 66, 873-884.
11. Coppes, M.J., Liefers, G.J., Paul, P., Yeger, H. and Williams, B.R.G. (1993) Homozygous somatic WT1 point mutations in sporadic unilateral Wilms tumor. Proc. Natl Acad. Sci. USA, 90, 1416-1419.
12. Czerny, T., Schaffner, G. and Busslinger, M. (1993) DNA sequence recognition by Pax proteins: bipartite structure of the paired domain and its binding site. Genes Dev., 7, 2048-2061.
13. Dehbi, M., Ghahremani, M., Lechner, M., Dressler, G. and Pelletier, J. (1996) The paired-box transcription factor, PAX2, positively modulates expression of the Wilms tumor suppressor gene (WT1). Oncogene, in press.
14. Dey, B.R., Sukhatme, V.P., Roberts, A.B., Sporn, M.B., Rauscher, F.J., III and Kim, S.-J. (1994) Repression of the transforming growth factor-β1 gene by the Wilms tumor suppressor WT1 gene product. Mol. Endocrinol., 8, 595-602.
15. Dressler, G.R. and Douglass, E.C. (1992) Pax-2 is a DNA binding protein expressed in embryonic kidney and Wilms tumor. Proc. Natl Acad. Sci. USA, 89, 1179-1183.
16. Dressler, G.R., Wilkinson, J.E., Rothenpieler, U.W., Petterson, L.T., Williams-Simons, L. and Westphal, H. (1993) Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature, 362, 65-67.
17. Drummond, I.A., Madden, S.L., Rohwer-Nutter, P., Bell, G.L., Sukhatme, V.P. and Rauscher, F.J., III (1992) Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor gene WT1. Science, 257, 674-678.
18. Eccles, M.R., Yun, K., Reeve, A.E. and Fidler, A.E. (1995) Comparative in situ hybridization analysis of Pax2, Pax8 and WT1 gene transcription in human fetal kidney and Wilms tumors. Am. J. Pathol., 146, 40-45.
19. Englert, C. et al. (1995) WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J., 14, 4662-4675.
20. Epstein, J., Cai, J., Glaser, T., Jepeal, L. and Maas, R. (1994) Identification of a Pax paired domain recognition sequence and evidence for DNA-dependent conformational changes. J. Biol. Chem., 269, 8355-8361.
21. Feinberg, A.P. and Vogelstein, B. (1983) A technique for radiolabeling DNA restriction fragments to high specific activity. Biochem. Biophys. Res. Commun., 111, 47-54.
22. Fraizer, G.C., Wu, Y.-J., Hewitt, S.M., Maity, T., Ton, C.C.T., Huff, V. and Saunders, G.F. (1994) Transcriptional regulation of the human Wilms tumor gene (WT1). J. Biol. Chem., 269, 8892-8900.
23. Francis-Lang, H., Price, M., Polycarpou-Schwarz, M. and Di Lauro, R. (1992) Cell-type specific expression of the rat thyroperoxidase promoter indicates common mechanisms for thyroid-specific gene expression. Mol. Cell. Biol., 12, 576-588.
24. Fridovich-Keil, J.L., Guda, J.M., Bouvard Bryan, L. and Pardee, A.B. (1991) Improved expression vectors for eukaryotic promoter/enhancer studies. Biotechniques, 11, 572-579.
25. Galili, N., Walton, D.S. and Maas, R.L. (1992) Genomic structure, evolutionary conservation and aniridia mutations in the human PAX gene. Nature Genet., 2, 232-238.
26. Gashler, A.L., Bonthron, D.T., Madden, S.L., Rauscher, F.J., III, Collins, T. and Sukhatme, V.P. (1992) Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. Proc. Natl Acad. Sci. USA, 89, 10984-10988.
27. Gessler, M., Poustka, A., Cavenee, W., Neve, R.L., Orkin, S.H. and Bruns, G.A.P. (1990) Homozygous deletion in Wilms tumors of a zinc finger gene identified by chromosome jumping. Nature, 343, 774-778.
28. Goodyer, P., Dehbi, M., Torban, E., Bruening, W. and Pelletier, J. (1995) Repression of the retinoic acid receptor-α gene by the Wilms tumor suppressor gene product, wtl. Oncogene, 10, 1125-1129.
29. Gorman, C. (1985) High efficiency gene transfer into mammalian cells. In Glover, D.M. (ed.), DNA Cloning. IRL Press Ltd, Oxford, UK, Vol. II, pp. 143-190.
30. Gruss, P. and Walther, C. (1992) Pax in development. Cell, 69, 719-722.
31. Haber, D.A., Sohn, R.L., Buckler, A.J., Pelletier, J., Call, K.M. and Housman, D.E. (1991) Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc. Natl Acad. Sci. USA, 88, 9618-9622.
32. Harrington, M.A., Konicek, B., Song, A., Xia, X., Fredericks, W.J. and Rauscher, F.J., III (1993) Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms tumor locus. J. Biol. Chem., 268, 21271-21275.
33. Hofmann, W., Royer, H.D., Drechsler, M., Schneider, S. and Royer-Pokora, B. (1993) Characterization of the transcriptional regulatory region of the human WT1 gene. Oncogene, 8, 3123-3132.
34. Holst, B.D., Goomer, R.S., Wood, I.C., Edelman, G.M. and Jones, F.S. (1994) Binding and activation of the promoter for the neural cell adhesion molecule by Pax-8. J. Biol. Chem., 269, 22245-22252.
35. Kozmik, Z., Kurzbauer, R., Drfler, P. and Busslinger, M. (1993) Alternative splicing of Pax-8 gene transcripts is developmentally regulated and generates isoforms with different transactivation properties. Mol. Cell. Biol., 13, 6024-6035.
36. Kriedberg, J.A., Sariola, H., Loring, J.M., Maeda, M., Pelletier, J., Housman, D. and Jaenisch, R. (1993) WT-1 is required for early kidney development. Cell, 7, 679-691.
37. Larrson, S.H., Charlieu, J.-P., Miyagawa, K., Engelkamp, D., Rassoulzadegan, M., Ross, A., Cuzin, F., van Heyningen, V. and Hastie, N.D. (1995) Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell, 81, 391-401.
38. Little, M.H., Prosser, J., Condie, A., Smith, P.J., van Heyningen, V. and Hastie, N.D. (1992) Zinc finger point mutations within the WT1 gene in Wilms tumor patients. Proc. Natl Acad. Sci. USA, 89, 4791-4795.
39. Maulbecker, C.C. and Gruss, P. (1993) The oncogenic potential of Pax genes. EMBO J., 6, 2361-2367.
40. McCann, S., Sullivan, J., Guerra, J., Arcinas, M. and Boxer, L.M. (1995) Repression of the c-myb gene by WT1 protein in T and B cell lines. J. Biol. Chem., 270, 23785-23789.
41. Mundlos, S., Pelletier, J., Darveau, A., Bachmann, M., Winterpacht, A. and Zabel, B. (1993) Nuclear localization of the protein encoded by the Wilms tumor gene WT1 in embryonic and adult tissues. Development, 119, 1329-1341.
42. Park, S., Bernard, A., Bove, K., Sens, D.A., Hazen-Martin, D.J., Julian Garvin, A. and Haber, D.A. (1993) Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms tumour. Nature Genet., 5, 363-367.
43. Paterson, L.T. and Dressler, G.R. (1994) The regulation of kidney development: new insights from an old model. Curr. Opin. Genet. Dev., 4, 696-702.
44. Pelletier, J. et al. (1991a) Germline mutations in the Wilms tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell, 67, 437-447.
45. Pelletier, J., Schalling, M., Buckler, A.J., Rogers, A., Haber, D.A. and Housman, D. (1991b) Expression of the Wilms tumor gene WT1 in the murine urogenital system. Genes Dev., 5, 1345-1356.
46. Plachov, D., Chowdhury, K., Whalther, C., Simon, D., Guenet, J.L. and Gruss, P. (1991) Pax8, a murine paired box gene expressed in the developing excretory system and thyroid gland. Development, 110, 643-651.
47. Poleev, A., Fickenscher, H., Mundlos, S., Winterpacht, A., Zabel, B., Fidler, A., Gruss, P. and Plachov, D. (1992) PAX8, a human paired box gene: isolation and expression in developing thyroid, kidney, and Wilms tumors. Development, 116, 611-623.
48. Poleev, A., Wendler, F., Fickenscher, H., Zannini, M.S., Yaginuma, K., Abbot, C. and Plachov, D. (1995) Distinct functional properties of three human paired-box-protein, PAX8, isoforms generated by alternative splicing in thyroid, kidney, and Wilms tumors. Eur. J. Biochem., 228, 899-911.
49. Pritchard-Jones, K. et al. (1990) The candidate Wilms tumour gene is involved in genitourinary development. Nature, 346, 194-197.
50. Rauscher, F.J., III (1993) The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J., 7, 896-903.
51. Rauscher, F.J., III, Morris, J.F., Tournay, O.E., Cook, D.M. and Curran, T. (1990) Binding of the Wilms tumor locus zinc finger protein to the EGR-1 consensus sequence. Science, 250, 1259-1262.
52. Rupprecht, H.D., Drummond, I.A., Madden, S.L., Rauscher, F.J., III and Sukhatme, V.P. (1994) The Wilms tumor suppressor gene WT1 is negatively autoregulated. J. Biol. Chem., 269, 6198-6206.
53. Ryan, G., Steele-Perkins, V., Morris, J.F., Rauscher, F.J., III and Dressler, G.R. (1995) Repression of Pax-2 by WT1 during normal kidney development. Development, 121, 867-875.
54. Shapiro, D.N., Sublett, J.E., Downing, J.R. and Naeve, C.W. (1993) Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res., 53, 5108-5112.
55. Stuart, E.T., Haffner, R., Oren, M. and Gruss, P. (1995) Loss of p53 function through PAX-mediated transcriptional repression. EMBO J., 14, 5638-5645.
56. Tagge, E.P., Hanson, P., Re, G.G., Othersen, H.B., Jr. Smith, C.D. and Garvin, A.J. (1994) Paired box gene expression in Wilms tumor. J. Pediatr. Surg., 29, 134-141.
57. Varanasi, R., Bardeesy, N., Ghahremani, M., Petruzzi, M.-J., Nowak, N., Adam, M.A., Grundy, P., Shows, T. and Pelletier, J. (1994) Fine structure analysis of the WT1 gene in sporadic Wilms tumors. Proc. Natl Acad. Sci. USA, 91, 3554-3558.
58. Wang, Z.Y., Madden, S.L., Deuel, T.F. and Rauscher, F.J., III (1992) The Wilms tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J. Biol. Chem., 267, 21999-22002.
59. Wang, Z.-Y., Qiu, Q.-Q., Gurriere, M., Huang, J. and Deuel, T.F. (1995) WT1, the Wilms tumor suppressor gene product, represses transcription through an interactive nuclear protein. Oncogene, 10, 1243-1247.
60. Weitzman, J.B., Pasgualini, R., Takada, Y. and Hemler, M.E. (1993) The function and distinctive regulation of the integrin VLA-3 in cell adhesion, spreading, and homotypic aggregation. J. Biol. Chem., 268, 8651-8657.
61. Werner, H., Re, G.G., Drummond, I.A., Sukhatme, V.P., Rauscher, F.J., III, Sens, D.A., Garvin, A.J., LeRoith, D. and Roberts, C.T., Jr (1993) Increased expression of the insulin-like growth factor 1 receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. Proc. Natl Acad. Sci. USA, 90, 5828-5832.
62. Wu, Y.-J., Fraizer, G.C. and Saunders, G.F. (1995) GATA-1 transactivates the WT1 hematopoietic specific enhancer. J. Biol. Chem., 270, 5944-5949.
63. Zannini, M., Francis-lang, H., Plachov, D. and Di Lauro, R. (1992) Pax-8, a paired domain-containing protein, binds to a sequence overlapping the recognition site of a homeodomain and activates transcription from two thyroid-specific promoters. Mol. Cell. Biol., 12, 4230-4241.